Skip to main content

Advertisement

Log in

Unrelated donor bone marrow transplantation with treosulfan-based myeloablative conditioning for paroxysmal nocturnal hemoglobinuria- successful treatment despite multiple transplant-related risk factors for hemolysis including major Kidd group incompatibility

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Saso R, Marsh J, Cevreska L, Szer J, Gale RP, Rowlings PA et al. Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol 1999; 104: 392–396.

    Article  CAS  Google Scholar 

  2. Woodard P, Wang W, Pitts N, Benaim E, Horwitz E, Cunningham J et al. Successful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. Bone Marrow Transplant 2001; 27: 589–592.

    Article  CAS  Google Scholar 

  3. Flotho C, Strahm B, Kontny U, Duffner U, Peters AM, Dupuis W et al. Stem cell transplantation for paroxysmal nocturnal haemoglobinuria in childhood. Br J Haematol 2002; 118: 124–127.

    Article  Google Scholar 

  4. Lee JL, Lee JH, Lee JH, Choi SJ, Kim S, Seol M et al. Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria. Eur J Haematol 2003; 71: 114–118.

    Article  Google Scholar 

  5. Hegenbart U, Niederwieser D, Forman S, Holler E, Leiblein S, Johnston L et al. Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant 2003; 9: 689–697.

    Article  CAS  Google Scholar 

  6. Jochen C, Blau W, Volin L, Ruutu T, Wandt H, Schaefer-Eckart K et al. Allogeneic haematopoietic stem cell transplantation after treosulfan/fludarabine conditioning in high-risk patients with hematologic malignancies. Dose escalation of treosulfan. Blood 2003; 102: 467a (abstract 1704).

    Google Scholar 

  7. Grosskreutz C, Ross V, Scigliano E, Fruchtman S, Isola L . Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation. Biol Blood Marrow Transplant 2003; 9: 453–459.

    Article  Google Scholar 

  8. Takahashi Y, McCoy JP Jr, Carvallo C, Rivera C, Igarashi T, Srinivasan R et al. In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation. Blood 2004; 103: 1383–1390.

    Article  CAS  Google Scholar 

  9. Chakrabarti S, Takahashi Y, Srinivasan R, Espinoza I, Igarashi T, Suffredini D et al. Durable engraftment and long-term survival following fludarabine-based nonmyeloablative hematopoietic cell transplantation (HCT) in patients with ATG-refractory severe aplastic anemia (SAA) and other nonmalignant hematological disorders. Blood 2004; 104: 252.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Markiewicz, M., Wojciechowska, M., Wyleżoł, I. et al. Unrelated donor bone marrow transplantation with treosulfan-based myeloablative conditioning for paroxysmal nocturnal hemoglobinuria- successful treatment despite multiple transplant-related risk factors for hemolysis including major Kidd group incompatibility. Bone Marrow Transplant 37, 231–232 (2006). https://doi.org/10.1038/sj.bmt.1705210

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705210

  • Springer Nature Limited

This article is cited by

Navigation